Marc Evanchik

Marc Evanchik is an experienced drug discovery and development consultant, specializing in preclinical target validation, safety evaluation, clinical pharmacology, and proof of concept. With a background in PK, PD, and ADME, Marc has held various senior roles in biopharmaceutical companies such as Assembly Biosciences, Inc., MyoKardia, and 3-V Biosciences. Marc's expertise lies in pioneering precision medicine approaches for the treatment of cardiovascular diseases.